Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
53,788,752
-
Total 13F shares
-
184,593
-
Share change
-
+174,593
-
Total reported value
-
$1,130,000
-
Price per share
-
$6.08
-
Number of holders
-
11
-
Value change
-
+$1,129,000
-
Number of buys
-
11
-
Number of sells
-
1
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) as of Q3 2022
As of 30 Sep 2022 ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 184,593 shares of stock of the company.
Largest 10 holders included Northeast Financial Consultants Inc, IEQ CAPITAL, LLC, BANK OF AMERICA CORP /DE/, CLARET ASSET MANAGEMENT Corp, JPMORGAN CHASE & CO, MORGAN STANLEY, UBS Group AG, ROYAL BANK OF CANADA, GABLES CAPITAL MANAGEMENT INC., and NATIONAL BANK OF CANADA /FI/.
This table shows 11 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.